Pursuant to Regulation 30 and other applicable Regulations of SEBI (LODR), 2015, the Board of Directors of the Company in its meeting held today i.e., on July 31, 2025: Approved the Un-Audited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Hindustan Bio Sciences Ltd met on July 31, 2025 and approved the unaudited standalone financial results for Q1 FY26 (quarter ended June 30, 2025). Revenue from operations stood at Rs 32.19 lakhs, down from Rs 41.11 lakhs in the same quarter last year, while profit before tax was Rs 1.40 lakhs versus Rs 8.18 lakhs in Q1 FY25. The Board accepted the resignation of Mr. Devanshu Ravinder Dange as Company Secretary, Compliance Officer and Key Managerial Personnel (KMP), effective July 31, 2025, citing personal reasons. Mr. Shailendra Vyas (an ICSI Associate Member) was appointed as the new Company Secretary, KMP and Compliance Officer from August 1, 2025. The Board also approved the notice for the 33rd Annual General Meeting, the Directors' Report, the Corporate Governance Report, adopted the Secretarial Audit Report for FY25, and appointed a scrutinizer for the AGM e-voting process.
For shareholders: Q1 results show a meaningful slowdown in revenue and earnings compared to last year, though the company remains profitable. The Company Secretary change is a routine KMP-level transition with no governance red flags, and a replacement was appointed immediately to ensure continuity.